Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

613
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
613
What is the Immune System?01:38

What is the Immune System?

113.2K
Overview
113.2K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

452
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
452
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.7K
Overview
69.7K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.0K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

986
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
986

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous dysbiosis in inherited ichthyoses/epidermal differentiation disorders: a prospective case-control study.

The Journal of investigative dermatology·2026
Same author

Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated Patients.

Cancers·2026
Same author

Mitochondrial toxins cause widespread downregulation of pathways in X-linked dystonia-parkinsonism patient-derived neurons.

Stem cell reports·2026
Same author

Adenosine Pathway Activation Defines Genetically Linked Immunosuppressive Subtypes in Solid Tumor Brain Metastases.

Cancers·2026
Same author

IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Blood·2026
Same author

IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.

Blood·2026
Same journal

Decoding gut microbiome alterations in celiac disease: Implications for pathogenesis and treatment.

Autoimmunity reviews·2026
Same journal

Rethinking immunosuppression in limited cutaneous systemic sclerosis. The lcSSc conundrum; pros and cons for a timely immunosuppressive treatment.

Autoimmunity reviews·2026
Same journal

Kidney failure in patients with ANCA-associated vasculitis: A systematic review of outcomes.

Autoimmunity reviews·2026
Same journal

The role of antimicrobial peptides in rheumatoid arthritis: From mucosal predisposition to chronic synovitis.

Autoimmunity reviews·2026
Same journal

The role of short-chain fatty acids as key mediators of gut microbiota - host crosstalk in thyroid diseases.

Autoimmunity reviews·2026
Same journal

Intermittent hydrarthrosis (periodic synoviosis): A narrative review.

Autoimmunity reviews·2026
See all related articles

Related Experiment Video

Updated: Aug 19, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

14.7K

Autoimmune pre-disease.

Katja Bieber1, Jennifer E Hundt1, Xinhua Yu2

  • 1Lübeck Institute of Experimental Dermatology and Center for Research on Inflammation of the Skin, University of Lübeck, Germany.

Autoimmunity Reviews
|November 27, 2022
PubMed
Summary
This summary is machine-generated.

Identifying biomarkers for autoimmune disease progression is crucial. This review explores the transition from harmless autoimmunity to clinical disease, highlighting current knowledge gaps and future research directions.

Keywords:
AutoimmunityDietDrugsEnvironmentPathogenesisPre-diseaseShift workSmoking

More Related Videos

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

935
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.8K

Related Experiment Videos

Last Updated: Aug 19, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

14.7K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

935
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.8K

Area of Science:

  • Immunology
  • Autoimmunity
  • Disease Pathogenesis

Background:

  • Autoimmune diseases affect 5% of the global population, posing significant treatment challenges and economic burdens.
  • Disease development is a multi-year process involving autoantigen-specific lymphocytes and autoantibodies, but not all individuals with autoantibodies develop clinical symptoms.
  • Identifying and intervening in the transition from harmless autoimmunity to inflammatory conditions is a critical unmet need.

Purpose of the Study:

  • To review the current understanding of autoimmune disease progression from health to clinically manifest disease.
  • To identify knowledge gaps in defining and modulating the autoimmune predisease phase.
  • To outline future research perspectives for targeting autoimmune predisease.

Main Methods:

  • Review of published scientific literature on autoimmune disease development.
  • Analysis of factors influencing the transition from harmless to inflammatory autoimmune responses.
  • Synthesis of current status, missing knowledge, and future directions in autoimmune predisease research.

Main Results:

  • The switch to inflammatory autoantigen-specific T and B-cell responses is a key factor in disease manifestation.
  • Biomarkers predicting progression from autoantibody presence to clinical disease are lacking.
  • Environmental and genetic factors significantly influence disease progression.

Conclusions:

  • Defining and targeting the autoimmune predisease phase holds significant therapeutic potential.
  • Further research is needed to develop predictive biomarkers and therapeutic strategies for autoimmune predisease.
  • Understanding the transition from harmless autoimmunity to inflammatory disease is essential for effective intervention.